Centre Asset Management Has Lowered Its Hca Holdings (HCA) Holding; Kepos Capital LP Has Decreased Pfizer (PFE) Stake By $4.00 Million

Centre Asset Management Llc decreased Hca Holdings Inc (HCA) stake by 36.48% reported in 2018Q3 SEC filing. Centre Asset Management Llc sold 32,410 shares as Hca Holdings Inc (HCA)’s stock rose 1.99%. The Centre Asset Management Llc holds 56,430 shares with $7.85 million value, down from 88,840 last quarter. Hca Holdings Inc now has $46.30 billion valuation. The stock increased 0.36% or $0.48 during the last trading session, reaching $134.54. About 2.23M shares traded or 11.10% up from the average. HCA Healthcare, Inc. (NYSE:HCA) has risen 57.68% since January 21, 2018 and is uptrending. It has outperformed by 57.68% the S&P500. Some Historical HCA News: 01/05/2018 – HCA HEALTHCARE STILL SEES FY ADJ EBITDA $8.45B TO $8.75B; 24/04/2018 – HCA Healthcare Bond Trading 2x Average; Clients Net Buyers; 08/05/2018 – HCA Healthcare at Deutsche Bank Health Care Conference Tomorrow; 21/05/2018 – HCA Healthcare Presenting at UBS Conference Tomorrow; 21/03/2018 – WLOS: BREAKING: @MissionHealthNC in negotiations to join HCA Healthcare #avlnews #LiveOnWLOS; 01/05/2018 – HCA Healthcare Sees 2018 EPS $8.50-EPS $9; 20/03/2018 – Ravi Chari Appointed President of HCA’s West Florida Division; 07/05/2018 – HCA Healthcare’s Gulf Coast Division Smashes Fundraising Goal for March of Dimes Walk for Babies; 09/04/2018 – Moody’s Upgrades Hca Healthcare’s Cfr To Ba1; Outlook Stable; 07/05/2018 – Factors of Influence in 2018, Key Indicators and Opportunity within HCA Healthcare, Apartment Investment and Management, KeyCor

Kepos Capital Lp decreased Pfizer Inc (PFE) stake by 55.15% reported in 2018Q3 SEC filing. Kepos Capital Lp sold 91,012 shares as Pfizer Inc (PFE)’s stock rose 5.56%. The Kepos Capital Lp holds 74,004 shares with $3.26 million value, down from 165,016 last quarter. Pfizer Inc now has $245.84B valuation. The stock increased 0.14% or $0.06 during the last trading session, reaching $42.53. About 36.64M shares traded or 44.57% up from the average. Pfizer Inc. (NYSE:PFE) has risen 25.07% since January 21, 2018 and is uptrending. It has outperformed by 25.07% the S&P500. Some Historical PFE News: 19/04/2018 – FDA STAFF – REVIEW OF LILLY RHEUMATOID ARTHRITIS TREATMENT HAS IDENTIFIED SERIOUS SAFETY RISK OF THROMBOSIS NOT SEEN IN OTHER THERAPIES, ESPECIALLY PFIZER’S XELJANZ; 08/05/2018 – XtalPi Inc. Announces Strategic Research Collaboration with Pfizer Inc. to Develop Artificial Intelligence-Powered Molecular Mo; 30/05/2018 – PFIZER: U.S. FDA OKS XELJANZ® (TOFACITINIB) FOR TREATMENT OF; 18/04/2018 – P&G Also Held Discussions With Pfizer Over Its Consumer Health Unit; 04/04/2018 – Riding a wave of positive PhIII readouts, Pfizer gets a snap review for lung cancer drug dacomitinib $PFE; 01/05/2018 – Pfizer Sees 2018 Effective Tax Rate on Adjusted Income About 17%; 20/04/2018 – P&G’s vitamin boost could signal more to come; 03/04/2018 – Pfizer and P&G are in talks on sale of consumer business, though far apart in price; 25/05/2018 – STAT Plus: Pharmalittle: Mylan pressures Pfizer to fix EpiPen production problems; AstraZeneca cancer drug hits important goal; 15/05/2018 – REXAHN PHARMACEUTICALS INC – SMC HAS CONFIRMED THAT COMBINATION OF RX-3117 AND ABRAXANE IS SAFE AND WELL TOLERATED

Among 7 analysts covering Pfizer ( NYSE:PFE ), 2 have Buy rating, 1 Sell and 4 Hold. Therefore 29% are positive. Pfizer had 9 analyst reports since August 1, 2018 according to SRatingsIntel. The firm has “Buy” rating by Bank of America given on Wednesday, August 1. The firm has “Sell” rating given on Tuesday, November 6 by Citigroup. The stock of Pfizer Inc. (NYSE:PFE) has “Equal-Weight” rating given on Thursday, August 23 by Barclays Capital. The firm has “Neutral” rating by Credit Suisse given on Wednesday, August 1. The firm earned “Overweight” rating on Thursday, August 23 by Morgan Stanley. The firm has “Neutral” rating by JP Morgan given on Tuesday, December 11. The rating was maintained by Credit Suisse on Wednesday, October 31 with “Neutral”. BMO Capital Markets maintained Pfizer Inc. (NYSE:PFE) rating on Wednesday, August 1. BMO Capital Markets has “Outperform” rating and $44 target. BMO Capital Markets downgraded the shares of PFE in report on Thursday, November 1 to “Market Perform” rating.

Since August 13, 2018, it had 0 buys, and 1 sale for $418,774 activity. $418,774 worth of Pfizer Inc. (NYSE:PFE) was sold by OLSON LAURIE J on Monday, August 13.

Analysts await Pfizer Inc. (NYSE:PFE) to report earnings on January, 29 before the open. They expect $0.64 EPS, up 3.23% or $0.02 from last year’s $0.62 per share. PFE’s profit will be $3.70 billion for 16.61 P/E if the $0.64 EPS becomes a reality. After $0.78 actual EPS reported by Pfizer Inc. for the previous quarter, Wall Street now forecasts -17.95% negative EPS growth.

More important recent Pfizer Inc. (NYSE:PFE) news were published by: Investorplace.com which released: “Should You Buy PFE Stock on Pfizer’s Joint Venture With Glaxo? – Investorplace.com” on December 26, 2018, also Seekingalpha.com published article titled: “Pfizer to shutter two plants in India – Seeking Alpha”, Streetinsider.com published: “Pfizer (PFE) Enters Collaboration Agreement with CytoReason – StreetInsider.com” on January 07, 2019. More interesting news about Pfizer Inc. (NYSE:PFE) was released by: Investorplace.com and their article: “3 Big Stock Charts for Thursday: Fiserv, Pfizer and PNC Financial Services Group – Investorplace.com” with publication date: January 17, 2019.

Investors sentiment increased to 0.85 in Q3 2018. Its up 0.07, from 0.78 in 2018Q2. It increased, as 41 investors sold PFE shares while 741 reduced holdings. 142 funds opened positions while 520 raised stakes. 3.96 billion shares or 0.44% less from 3.98 billion shares in 2018Q2 were reported. Moreover, Girard Prtn Ltd has 0.72% invested in Pfizer Inc. (NYSE:PFE). Cornerstone Cap reported 0.05% of its portfolio in Pfizer Inc. (NYSE:PFE). Moreover, Puzo Michael J has 0.27% invested in Pfizer Inc. (NYSE:PFE). First Interstate State Bank holds 30,021 shares or 0.28% of its portfolio. Fcg Limited Liability Com owns 16,065 shares. Swiss National Bank holds 1.01% or 20.56 million shares in its portfolio. Murphy Pohlad Asset Mgmt Ltd Liability holds 1.43% or 52,647 shares. B Riley Wealth Inc has invested 0.39% in Pfizer Inc. (NYSE:PFE). Balyasny Asset Ltd Liability Corp invested 0.09% in Pfizer Inc. (NYSE:PFE). Roffman Miller Pa has 16,918 shares. Woodley Farra Manion Portfolio Management holds 137,256 shares or 0.63% of its portfolio. Wealthfront invested in 196,627 shares. First Wilshire Secs Management has invested 0.11% in Pfizer Inc. (NYSE:PFE). Pzena Invest Lc stated it has 4.44 million shares or 0.95% of all its holdings. Mitchell Mcleod Pugh & Williams stated it has 0.56% in Pfizer Inc. (NYSE:PFE).

Kepos Capital Lp increased Motorola Solutions Inc (NYSE:MSI) stake by 48,883 shares to 55,239 valued at $7.19 million in 2018Q3. It also upped Ishares Etfs/Usa (LQD) stake by 14,800 shares and now owns 272,700 shares. Centurylink Inc (NYSE:CTL) was raised too.

Analysts await HCA Healthcare, Inc. (NYSE:HCA) to report earnings on January, 29. They expect $2.59 earnings per share, up 22.17% or $0.47 from last year’s $2.12 per share. HCA’s profit will be $891.37M for 12.99 P/E if the $2.59 EPS becomes a reality. After $2.16 actual earnings per share reported by HCA Healthcare, Inc. for the previous quarter, Wall Street now forecasts 19.91% EPS growth.

Investors sentiment decreased to 0.82 in 2018 Q3. Its down 0.32, from 1.14 in 2018Q2. It turned negative, as 33 investors sold HCA shares while 235 reduced holdings. 78 funds opened positions while 142 raised stakes. 234.20 million shares or 2.05% less from 239.10 million shares in 2018Q2 were reported. California Pub Employees Retirement Systems has invested 0.2% of its portfolio in HCA Healthcare, Inc. (NYSE:HCA). 14.98M were accumulated by Wellington Management Gp Llp. Virtu Financial Limited Liability holds 5,250 shares or 0% of its portfolio. Teachers Retirement Systems Of The State Of Kentucky, a Kentucky-based fund reported 26,850 shares. Icon Advisers owns 52,381 shares or 0.62% of their US portfolio. Meiji Yasuda Asset Management holds 16,495 shares. Zurcher Kantonalbank (Zurich Cantonalbank) reported 0.2% stake. Art Limited Liability Corporation reported 19,280 shares. Moreover, Walleye Trading Ltd Liability has 0.01% invested in HCA Healthcare, Inc. (NYSE:HCA) for 9,366 shares. The Maryland-based Fort LP has invested 0.03% in HCA Healthcare, Inc. (NYSE:HCA). Leuthold Gru Ltd Co owns 124,358 shares for 1.89% of their portfolio. Spark Mngmt Ltd Limited Liability Company holds 0.4% in HCA Healthcare, Inc. (NYSE:HCA) or 50,100 shares. Convergence Investment Prtn Llc owns 0.28% invested in HCA Healthcare, Inc. (NYSE:HCA) for 9,897 shares. Victory Cap owns 682,928 shares. Qs Invsts Limited Liability Company holds 10,933 shares.

More recent HCA Healthcare, Inc. (NYSE:HCA) news were published by: Seekingalpha.com which released: “HCA offers $1B senior notes – Seeking Alpha” on January 17, 2019. Also Bizjournals.com published the news titled: “Baylor St. Luke’s Medical Center appoints new execs as part of leadership shake-up – Houston Business Journal” on January 19, 2019. Seekingalpha.com ‘s news article titled: “Centene finishes first, Coty last on S&P 500 for 2018 – Seeking Alpha” with publication date: December 31, 2018 was also an interesting one.

Among 12 analysts covering HCA Healthcare ( NYSE:HCA ), 10 have Buy rating, 2 Sell and 0 Hold. Therefore 83% are positive. HCA Healthcare has $165 highest and $115 lowest target. $149.42’s average target is 11.06% above currents $134.54 stock price. HCA Healthcare had 14 analyst reports since July 27, 2018 […]

Click Here to Continue...

Add a Comment

Your email address will not be published. Required fields are marked *